Where does Acadia Healthcare's income statement data come from?

Every line is extracted from Acadia Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net interest income	-$148.01M-25.1%	-$138.86M-19.3%	-$131.01M-22.7%	-$124.32M-27.4%	-$118.34M-32.5%
Total revenue	$3.37B+6.8%	$3.31B+5.0%	$3.27B+4.6%	$3.23B+5.6%	$3.16B+5.5%
Compensation and benefits	$1.84B+7.2%	$1.82B+7.7%	$1.79B+7.2%	$1.75B+7.3%	$1.72B+7.5%
Occupancy and equipment	$48.1M+0.9%	$48.02M+0.3%	$47.72M-0.2%	$48.38M+2.6%	$47.65M+1.4%
Professional fees	$202.97M+7.0%	$195.48M+3.0%	$194.62M+3.6%	$191.64M+3.7%	$189.73M+5.1%
Depreciation and amortization	$194.64M+21.4%	$189.25M+26.5%	$183.04M+25.9%	$173.21M+22.7%	$160.28M+16.9%
Goodwill impairment	——	$996.2M—	——	——	——
Acquisition and integration costs	$154.57M+106%	$163.63M+250%	$167.98M+220%	$133.31M+141%	$74.98M+28.4%
Other operating expenses	$570.39M+25.7%	$553.31M+25.5%	$495.09M+17.6%	$478.44M+15.9%	$453.72M+13.7%
Total costs & expenses	$4.44B+53.1%	$4.38B+55.7%	$3.12B+14.1%	$3.03B-1.0%	$2.9B-3.5%
Other income (expense), net	——	——	——	——	——
Gain (loss) on extinguishment of debt	——	——	——	——	——
Gain (loss) on disposal of assets	——	——	——	——	——
Income before income taxes	-$1.07B-517%	-$1.07B-412%	$141.46M—	$200.05M—	$256.5M—
Income tax expense	$28.08M-54.5%	$25.98M-66.4%	$22.62M—	$48.15M—	$61.73M—
Net income	-$1.11B-690%	-$1.1B-531%	$107.36M-61.8%	$139.25M+2,822%	$187.6M+1,760%
Net margin	-32.8%-38.8pp	-33.3%-41.4pp	3.3%-5.7pp	4.3%+4.5pp	5.9%+6.3pp
Net income attributable to noncontrolling interests	——	——	——	——	——
Diluted earnings per share	-$12.20-698%	-$12.16-537%	$1.18—	$1.52—	$2.04—
Basic earnings per share	-$12.20-698%	-$12.16-536%	$1.17—	$1.51—	$2.04—
Weighted-average shares, diluted	362.6M-1.6%	363.8M-1.2%	365.1M-0.6%	366.7M+0.2%	368.3M+0.7%
Weighted-average shares, basic	362M-1.3%	363.1M-0.9%	364M-0.4%	365.3M+0.1%	366.6M+0.6%
Adjustments To Additional Paid In Capital Other	——	——	——	——	——
Share-based compensation expense related to employee stock plans	$30.99M-16.5%	$31.71M-14.6%	$35.36M-2.2%	$38.79M+11.3%	$37.11M+11.3%
Amortization Of Financing Costs	$5.06M+22.6%	$4.86M+19.0%	$4.54M+16.5%	$4.33M+16.9%	$4.13M+17.5%
Business Exit Costs1	——	——	——	——	——
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation	——	——	——	——	——
Contract With Customer Liability Revenue Unrecognized	——	——	——	——	$23.08M—
Deferred taxes	——	——	$14.88M+192%	$19.94M+136%	$44.61M+158%
Effective tax rates	——	——	——	——	——
Fair Value Of Assets Acquired	$51.17M+116%	$53.65M-9.4%	$36.72M-39.7%	$23.44M-60.3%	$23.69M-60.8%
Gain/(loss) on dispositions, net	——	——	——	——	——
Goodwill Additions	——	——	——	——	——
Goodwill impairment losses	——	$996.2M—	——	——	——
Government Investigations	——	——	——	——	——
Accounts payable and other current liabilities	——	——	$17.63M—	$6.41M—	-$30.52M—
Increase (Decrease) in Accounts Receivable	$75.18M—	$75.02M—	——	——	——
Accrued compensation and employee benefits	$11.91M—	$26.68M—	$19.11M—	——	——
Increase (Decrease) in Other Current Assets	——	——	——	——	——
Increase (decrease) in other current liabilities	——	——	——	$24.44M—	$23.23M—
Increase (decrease) in other assets	$10.62M—	$11.29M—	——	——	——
Interest Income (Expense), Operating	-$148.01M-25.1%	-$138.86M-19.3%	-$131.01M-22.7%	-$124.32M-27.4%	-$118.34M-32.5%
Legal Accounting And Other Acquisition Related Costs	——	——	——	——	——
Settlement amount awarded	——	——	——	——	——
Management Transition Costs	——	——	——	——	——
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	$318.47M+5.3%	$481.25M-19.6%	$368.76M-28.0%	$359.85M-21.2%	$302.38M-30.0%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$433.19M+41.1%	-$556.21M+24.5%	-$667.11M-3.7%	-$730.4M-26.0%	-$735.1M-42.8%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	——	——	$334.89M+159%	$424.81M+308%	$462.46M+378%
Net Income Loss Attributable To Noncontrolling Interest	——	——	——	——	——
Net Income Loss Attributable To Redeemable Noncontrolling Interest	$10.52M—	$10.85M—	——	——	——
Number Of Facilities	——	——	——	——	——
Number Of Facilities Operated By Non Wholly Owned Subsidiaries	——	——	——	——	——
Number of reportable segments	——	——	——	——	——
Occupancy and Related Charges	$48.1M+0.9%	$48.02M+0.3%	$47.72M-0.2%	$48.38M+2.6%	$47.65M+1.4%
Other Noncash Income (Expense)	——	——	-$1.21M-150%	-$384K-119%	$671K-66.7%
Payment for (Proceeds from) Other Investing Activity	——	——	$189K-94.0%	$147K-96.5%	$2.13M-6.3%
Payments for Repurchase of Common Stock	——	——	——	——	——
Payments of Debt Issuance Costs	——	——	——	——	——
Payments Of Distributions To Affiliates	——	——	——	——	——
Payments Of Dividends Minority Interest	——	——	——	——	——
Payments to Acquire Businesses, Net of Cash Acquired	——	——	——	——	$11.79M-76.7%
Payments to Acquire Property, Plant, and Equipment	$473.74M-34.4%	$571.81M-17.2%	$682.11M+9.0%	$736.11M+30.6%	$722.61M+44.5%
Proceeds From Contributions From Affiliates	——	——	——	——	——
Dividends received from unconsolidated affiliates	$70.92M—	$67.5M—	——	——	——
Debt issued (Note 13)	——	——	——	——	——
Financing — other	-$98K—	-$93K—	——	——	——
Proceeds From Payments For Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises	——	——	——	——	——
Dispositions of property, plant, and equipment	$40.19M+2,726%	$23.85M+129%	$23.36M-40.1%	$16.85M-56.8%	$1.42M-96.3%
Redeemable Noncontrolling Interest Resulting From An Acquisition	$51.01M—	$44.59M—	——	——	——
Repayments of Long-term Lines of Credit	——	——	——	——	——
Repayments of Secured Debt	——	——	——	——	——
Payments on debt	——	——	——	——	——
Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises	-$5.03M+6.3%	-$4.23M+50.6%	-$4.49M+49.0%	-$5.02M+43.5%	-$5.37M+38.8%
Revenue From Contract With Customer Excluding Assessed Tax	$3.37B+6.8%	$3.31B+5.0%	$3.27B+4.6%	$3.23B+5.6%	$3.16B+5.5%
Stock-based compensation	$30.99M-16.5%	$31.71M-14.6%	$35.36M-2.2%	$38.79M+11.3%	$37.11M+11.3%
Granted (in shares)	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period	——	——	——	——	——
Forfeited or expired (in shares)	——	——	——	——	——
Granted (in shares)	——	——	——	——	——
Value of shares repurchased	——	$50.42M—	——	——	——
Supplies Expense	$119.2M+4.2%	$118.05M+4.7%	$115.85M+4.5%	$115.06M+6.2%	$114.4M+7.3%
Unrecognized tax benefit, penalty expense (benefit)	——	——	——	——	——
Add: dilutive effect of potential common shares (in shares)	——	——	——	——	——
EBITDA	-$873.8M-310%	-$876.69M-278%	$324.5M—	$373.26M—	$416.78M—
EBITDA margin	-25.9%-39.1pp	-26.5%-42.0pp	9.9%—	11.6%—	13.2%—
EBIT	-$1.07B-517%	-$1.07B-412%	$141.46M—	$200.05M—	$256.5M—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Acadia Healthcare's income statement data come from?: Every line is extracted from Acadia Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.